Update shared on03 Sep 2025
Fair value Increased 3.58%Despite unchanged revenue growth forecasts and only a marginal uptick in future P/E, LIXIL's fair value has been revised upward, with the consensus analyst price target increasing from ¥1861 to ¥1928.
Valuation Changes
Summary of Valuation Changes for LIXIL
- The Consensus Analyst Price Target has risen slightly from ¥1861 to ¥1928.
- The Consensus Revenue Growth forecasts for LIXIL remained effectively unchanged, at 2.5% per annum.
- The Future P/E for LIXIL remained effectively unchanged, moving only marginally from 21.59x to 21.99x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.